We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Millbrook Scnce | LSE:MBK | London | Ordinary Share | GB0031612616 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.375 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMBK RNS Number : 4648Z Millbrook Scientific InstrumentsPLC 22 September 2009 Millbrook Scientific Instruments plc ('Millbrook' or the 'Group') Trading Update and Notification of Results As reported in the Group's trading update announced on 5 June 2009, the order intake for Millbrook Instruments Limited ("MIL"), the Group's subsidiary which manufactures the MiniSIMS instrument, decreased in the first quarter of the 2010 financial year. The Board believed that this would create pressure on the working capital of the Group if no action was taken and, given the level of fixed costs in the MiniSIMS business and the lumpy nature of its sales, the Board therefore resolved that it would implement a programme to cut costs and conserve cash whilst it considered its strategic options in respect of the MIL business. In the second quarter of the financial year, the Board has cut costs in the MiniSIMS business with the active cooperation of its staff but unfortunately, despite the best efforts of MIL's management, the order intake has not picked up significantly and MIL has continued to be cash flow negative for the Group. This has increased pressure on the working capital of the Group as a whole. In light of the above and following the completion of the strategic review of the MiniSIMS business which was undertaken in conjunction with Zeus Capital, the Group's financial adviser, the Board has, with regret, taken the decision to place MIL into administration. The Board believes that this action is in the best interests of shareholders since it will stop the cash burn associated with the MIL business, allow management to focus on the Group's other subsidiary, Micro Materials Limited and should enable the financial position of the Group to be stabilised. The Board is pleased to announce that Micro Materials Limited, the subsidiary based in Wrexham which manufactures the NanoTest, continues to trade satisfactorily in a difficult economic environment. The Board will continue to explore ways in which to develop the NanoTest business while also seeking to reduce central costs further, in light of the reduction in size of the Group. As announced previously, the Group expected to announce the results for the financial year ended 31 March 2009 in the week commencing 21 September 2009. The Group now expects to publish its annual audited accounts in the week commencing 5 October 2009. AIM Rule 19 requires an AIM company to publish annual audited accounts not later than six months after the end of the financial year. Since Millbrook will be in breach of AIM Rule 19, trading in Millbrook's shares will be suspended until the annual audited accounts are published. The registered office of Millbrook has been changed to Willow House, Yale Business Village, Ellice Way, Wrexham Technology Park, Wrexham, LL13 7YL. For more information please contact:- +-------------+----------+ | Millbrook | | | Scientific | | | Instruments | | | plc | | | Stephen | | | Blank, | | | Chairman | | | Paul | | | Grasske, | | | Chief | | | Executive | | | Officer | | | | | +-------------+----------+ Tel: +44 (0) 1978 261 615 www.millbrook-instruments.com Zeus Capital Limited Alex Clarkson /Tom Rowley Tel: +44 (0)161 831 1512 www.zeuscapital.co.uk This information is provided by RNS The company news service from the London Stock Exchange END TSTCKBKKBBKDBCB
1 Year Millbrook Scientific Chart |
1 Month Millbrook Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions